RE-SONANCE Trademark

Trademark Overview

On Monday, February 29, 2016, a trademark application was filed for RE-SONANCE with the United States Patent and Trademark Office. The USPTO has given the RE-SONANCE trademark a serial number of 79192538. The federal status of this trademark filing is REGISTERED as of Tuesday, September 4, 2018. This trademark is owned by Boehringer Ingelheim International GmbH. The RE-SONANCE trademark is filed in the Education & Entertainment Services category with the following description:

Publication of printed matter with the results of clinical studies involving pharmaceutical preparations; all of the foregoing relating to pharmaceutical preparations containing dabigatran
re-sonance

General Information

Serial Number79192538
Word MarkRE-SONANCE
Filing DateMonday, February 29, 2016
Status700 - REGISTERED
Status DateTuesday, September 4, 2018
Registration Number5552655
Registration DateTuesday, September 4, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 19, 2018

Trademark Statements

Goods and ServicesPublication of printed matter with the results of clinical studies involving pharmaceutical preparations; all of the foregoing relating to pharmaceutical preparations containing dabigatran

Classification Information

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateTuesday, October 4, 2016
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIngelheim 55218
DE
Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDE

Trademark Events

Event DateEvent Description
Thursday, November 10, 2016REFUSAL PROCESSED BY MPU
Saturday, October 1, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, October 4, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 4, 2016ASSIGNED TO EXAMINER
Wednesday, October 5, 2016NON-FINAL ACTION WRITTEN
Thursday, October 6, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, October 8, 2016APPLICATION FILING RECEIPT MAILED
Thursday, October 27, 2016NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Tuesday, November 8, 2016NON-FINAL ACTION WRITTEN
Wednesday, November 9, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, December 4, 2017TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, December 4, 2017EXPARTE APPEAL RECEIVED AT TTAB
Thursday, November 10, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, November 22, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, November 25, 2016REFUSAL PROCESSED BY IB
Wednesday, May 10, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 10, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 11, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 2, 2017FINAL REFUSAL WRITTEN
Friday, June 2, 2017FINAL REFUSAL E-MAILED
Friday, June 2, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, December 4, 2017EX PARTE APPEAL-INSTITUTED
Wednesday, February 28, 2018NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, December 4, 2017JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, December 11, 2017ASSIGNED TO LIE
Tuesday, December 12, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 12, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 5, 2018ACTION CONTINUING FINAL - COMPLETED
Friday, January 5, 2018ACTION DENYING REQ FOR RECON E-MAILED
Friday, January 5, 2018NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Wednesday, May 30, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 28, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, March 16, 2018NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Thursday, April 12, 2018JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, May 15, 2018EXAMINERS AMENDMENT -WRITTEN
Tuesday, May 15, 2018EXAMINERS AMENDMENT E-MAILED
Tuesday, May 15, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, May 15, 2018EXAMINER'S AMENDMENT ENTERED
Tuesday, May 15, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 15, 2018EXPARTE APPEAL TERMINATED
Friday, December 14, 2018FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, May 30, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 30, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, June 19, 2018PUBLISHED FOR OPPOSITION
Tuesday, June 19, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 4, 2018REGISTERED-PRINCIPAL REGISTER
Friday, September 21, 2018NOTIFICATION PROCESSED BY IB
Thursday, October 11, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 4, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, December 14, 2018FINAL DISPOSITION PROCESSED
Monday, September 4, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Saturday, January 5, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, July 26, 2024TEAS SECTION 71 RECEIVED
Monday, February 3, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, February 20, 2025TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Monday, February 3, 2025POST REGISTRATION ACTION MAILED - SEC.71

Related Keywords

sonance pharmaceutical preparations foregoing containing dabigatran relating involving matter printed results